- Snow Shoveling, Slips on Ice Bring Cold Weather Dangers
- How Moving the Homeless to Hotels During the Pandemic Helps Everyone
- With 3 COVID Vaccines Approved, Is There a ‘Best’ Shot?
- It’s Too Soon to Lift COVID Restrictions: Fauci
- Health Highlights: March 5, 2021
- AHA News: Why Did Yankees Manager Get a Pacemaker, and How Does It Work?
- When Facebook, Twitter Flag Posts as ‘Unverified,’ Readers Listen
- Lockdowns Tied to Temporary Drops in Illicit Drug Seizures
- Formaldehyde in Hair Straighteners Prompts FDA Warning
- Big Paychecks Pay Off in Self-Confidence, Study Finds
Clinical Trials Update: April 2, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Relapsing Remitting Multiple Sclerosis
This study of an investigational drug taken every four weeks is for people who have relapsing remitting multiple sclerosis.
The research site is in Sunrise, Fla.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/multiple_sclerosis.aspx.
—–
Tinnitus (Ringing of the Ears)
This 29-week study will evaluatie an investigational drug in people with tinnitus. Candidates must be at aged 18 to 75 and have persistent tinnitus in one or both ears.
The research site is in Gilbert, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/tinnitus.aspx.
—–
Gout
Participants in this study of gout will receive study-related medication, doctor visits, possible compensation and transportation.
The research site is in Costa Mesa, Calif.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
